Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Kerridge

Showing results (111-120 of 308) with videos related to

Pageof 31
Sort By:
AJOB Neuroscience|October 24, 2019
Beyond Flourishing: Intersecting Uses and Interests in the Neurotechnology MarketplaceCynthia Forlini, Wendy Lipworth, Adrian Carter, et al.
Medical Education|January 29, 2008
Do patients have an obligation to participate in student teaching?Michael Lowe, Ian Kerridge, John McPhee, et al.
International Journal of Clinical Pharmacy|October 3, 2020
Pharmacist review of high-risk haematology outpatients to improve appropriateness of antifungal prophylaxisZainab Reslan, Julian Lindsay, Ian Kerridge, et al.
Health Economics, Policy, and Law|November 1, 2019
Physicians' attitudes towards accelerated access to medicinesJessica Pace, Ian Kerridge, Sallie Pearson, et al.
The American Journal of Bioethics : AJOB|October 20, 2015
Destigmatising the Placebo EffectMark H Arnold, Damien G Finniss, Ian Kerridge
Internal Medicine Journal|November 7, 2017
Caution needed in introduction of provisional approvals for medicinesJessica Pace, Narcyz Ghinea, Ian Kerridge, et al.
Journal of Bioethical Inquiry|March 20, 2023
Going the Distance : Ethics of Space and Location on Accessing Reproductive Services in AustraliaAngie Sassano, Christopher Mayes, Ian Kerridge, et al.
Journal of Medical Ethics|May 29, 2020
Are my religious beliefs anyone's business? A framework for declarations in health and biomedicineNarcyz Ghinea, Miriam Wiersma, Ian Kerridge, et al.
Health Policy (Amsterdam, Netherlands)|July 30, 2018
An ethical framework for the creation, governance and evaluation of accelerated access programsJessica Pace, Narcyz Ghinea, Ian Kerridge, et al.
JCO Precision Oncology|February 17, 2022
Use of Real-World Data for the Research, Development, and Evaluation of Oncology Precision MedicinesJan R R Lewis, Ian Kerridge, Wendy Lipworth
Pageof 31

Showing results (111-120 of 308) with videos related to

Sort By:
Pageof 31
AJOB Neuroscience|October 24, 2019
Beyond Flourishing: Intersecting Uses and Interests in the Neurotechnology MarketplaceCynthia Forlini, Wendy Lipworth, Adrian Carter, et al.
Medical Education|January 29, 2008
Do patients have an obligation to participate in student teaching?Michael Lowe, Ian Kerridge, John McPhee, et al.
International Journal of Clinical Pharmacy|October 3, 2020
Pharmacist review of high-risk haematology outpatients to improve appropriateness of antifungal prophylaxisZainab Reslan, Julian Lindsay, Ian Kerridge, et al.
Health Economics, Policy, and Law|November 1, 2019
Physicians' attitudes towards accelerated access to medicinesJessica Pace, Ian Kerridge, Sallie Pearson, et al.
The American Journal of Bioethics : AJOB|October 20, 2015
Destigmatising the Placebo EffectMark H Arnold, Damien G Finniss, Ian Kerridge
Internal Medicine Journal|November 7, 2017
Caution needed in introduction of provisional approvals for medicinesJessica Pace, Narcyz Ghinea, Ian Kerridge, et al.
Journal of Bioethical Inquiry|March 20, 2023
Going the Distance : Ethics of Space and Location on Accessing Reproductive Services in AustraliaAngie Sassano, Christopher Mayes, Ian Kerridge, et al.
Journal of Medical Ethics|May 29, 2020
Are my religious beliefs anyone's business? A framework for declarations in health and biomedicineNarcyz Ghinea, Miriam Wiersma, Ian Kerridge, et al.
Health Policy (Amsterdam, Netherlands)|July 30, 2018
An ethical framework for the creation, governance and evaluation of accelerated access programsJessica Pace, Narcyz Ghinea, Ian Kerridge, et al.
JCO Precision Oncology|February 17, 2022
Use of Real-World Data for the Research, Development, and Evaluation of Oncology Precision MedicinesJan R R Lewis, Ian Kerridge, Wendy Lipworth
Pageof 31